# Congressional stock trades in MMSI (Merit Medical Systems Inc)

Congressional stock trades in Merit Medical Systems Inc (MMSI) from House and Senate STOCK Act filings. See which members of Congress bought or sold, disclosed amounts, and filing dates.

- Industry: Surgical & Medical Instruments & Apparatus
- Last close: $85.37
- Price updated: Sep 19, 2026
- Total congressional trades: 2
- Politicians trading: 1
- Last traded: Sep 25, 2025
- Source: https://tryglasshouse.ai/companies/MMSI.md

## Trading History

- Page: 1 of 1
- Results: 2 of 2
- Pagination query parameter: `page`

## 1. Lisa C. McClain

- Member: Republican, House
- Transaction: Sell, $1,001 - $15,000
- Dates: traded Sep 25, 2025, disclosed Oct 22, 2025
- Market context: $80.06 at trade, $85.37 current (+6.63%)
- Politician: https://tryglasshouse.ai/politicians/M001136.md
- Record: https://tryglasshouse.ai/trades/b9e80061-5305-44f4-8dcc-3987ab401fb5.md

## 2. Lisa C. McClain

- Member: Republican, House
- Transaction: Buy, $1,001 - $15,000
- Dates: traded Jul 22, 2025, disclosed Aug 13, 2025
- Market context: $84.47 at trade, $85.37 current (+1.07%)
- Politician: https://tryglasshouse.ai/politicians/M001136.md
- Record: https://tryglasshouse.ai/trades/a74cc9eb-24f0-4a9b-88b1-2e638e7385b6.md



## About Merit Medical Systems Inc

Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment which consists of cardiology and radiology medical device products that assist in diagnosing and treating coronary artery disease, peripheral vascular disease, and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, and interventional oncology and spine devices.

Prices and percentage changes are market context, not portfolio returns. This information is not financial advice.
